PTC Therapeutics, Inc.
PTCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070081
In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding PTC Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 206 | 2 | 181 | −23 |
| Shares | 81.1M | 692.5K | 81.2M | +758.2K (+0.9%) |
| Value | $3.30B | $28.2M | $1.83B | −$1.44B (−44.0%) |
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held PTC Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 804,358 | $18.0M | 0.02% |
| Great Point Partners LLC | 500,000 | $11.2M | 2.11% |
| Renaissance Technologies LLC | 234,600 | $5.26M | 0.01% |
| Voloridge Investment Management, LLC | 173,233 | $3.88M | 0.02% |
| Seven Eight Capital, LP | 64,722 | $1.45M | 0.17% |
| Boothbay Fund Management, LLC | 35,787 | $802.0K | 0.03% |
| Hudson Bay Capital Management LP | 30,000 | $672.3K | 0.01% |
| Rathbone Brothers plc | 23,735 | $531.9K | 0.00% |
| Nebula Research & Development LLC | 21,858 | $489.8K | 0.26% |
| XTX Topco Ltd | 16,489 | $369.5K | 0.06% |
| Squarepoint Ops LLC | 13,500 | $302.5K | 0.00% |
| HighVista Strategies LLC | 13,237 | $296.6K | 0.14% |
| Virtu Financial LLC | 11,911 | $267.0K | 0.03% |
| Ikarian Capital, LLC | 10,862 | $243.4K | 0.09% |
| Qube Research & Technologies Ltd | 10,476 | $234.8K | 0.00% |
| KBC Group NV | 1,551 | $35.0K | 0.00% |
| West Paces Advisors Inc. | 1,000 | $22.4K | 0.01% |
| Acadian Asset Management LLC | 679 | $15.0K | 0.00% |
| Comerica Bank | 315 | $7.06K | 0.00% |
| Central Trust Co | 43 | $964 | 0.00% |
| Grove Bank & Trust | 18 | $403 | 0.00% |
| Steward Financial Group LLC | 15 | $0 | 0.00% |
Sold out (45)
Institutions that held PTC Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (2)
Institutions that held PTC Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 686,450 | $27.9M |
| PFS Investments Inc. | 6,055 | $246.0K |